Cancer Therapy Manchester NH

Cancer can affect every part of the body. Cancer treatment varies widely and may include anti-cancer drugs, radiation therapy, chemotherapy, surgery, biological therapies, bone marrow transplantations, targeted cancer therapies, and others. See below to learn more and to gain access to oncologists in Manchester, NH who provide cancer therapy.

Charles George Leutzinger, MD
(603) 628-1800
1 Elliot Way
Manchester, NH
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Univ Of Ct Sch Of Med, Farmington Ct 06032
Graduation Year: 1976

Data Provided by:
Thomas Andrew Sheldon, MD
(603) 669-5300
1 Elliot Way
Manchester, NH
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Tufts Univ Sch Of Med, Boston Ma 02111
Graduation Year: 1980
Hospital
Hospital: Elliot Hosp, Manchester, Nh
Group Practice: New Hampshire Medical Lab

Data Provided by:
Karen Jane Hoffmeister
(603) 629-1827
100 Hitchcock Way
Manchester, NH
Specialty
Hematology / Oncology

Data Provided by:
Charles Howard Catcher, MD
(603) 622-6484
200 Technology Dr
Hooksett, NH
Specialties
Oncology (Cancer), Internal Medicine
Gender
Male
Education
Medical School: Univ Of Mn Med Sch-Minneapolis, Minneapolis Mn 55455
Graduation Year: 1985
Hospital
Hospital: Elliot Hosp, Manchester, Nh; Concord Hosp, Concord, Nh
Group Practice: New Hampshire Oncology-Hmtlgy

Data Provided by:
Gina M Divenuti
(603) 622-6484
200 Technology Dr
Hooksett, NH
Specialty
Hematology / Oncology

Data Provided by:
Donald Raabe Weiss, MD
(603) 663-1800
1 Elliot Way
Manchester, NH
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Languages
Other
Education
Medical School: Univ Of Co Sch Of Med, Denver Co 80262
Graduation Year: 1965
Hospital
Hospital: St Joseph Hospital And Trauma, Nashua, Nh; Elliot Hosp, Manchester, Nh; Concord Hosp, Concord, Nh; Wentworth-Douglass Hospital, Dover, Nh; Exeter Hosp, Exeter, Nh
Group Practice: Elliot Regional Cancer Ctr

Data Provided by:
Brian Robert Knab
(603) 663-1800
1 Elliot Way
Manchester, NH
Specialty
Radiation Oncology

Data Provided by:
Jack Terry Evjy, MD
(978) 685-7811
21 Bowman Parade Rd
Bedford, NH
Specialties
Oncology (Cancer), Hematology-Internal Medicine
Gender
Male
Education
Medical School: Boston Univ Sch Of Med, Boston Ma 02118
Graduation Year: 1961
Hospital
Hospital: Holy Family Hosp And Med Ctr, Methuen, Ma
Group Practice: Commonwealth Hematology-Onclgy

Data Provided by:
Peter Holland Crow, MD
(603) 622-6484
200 Technology Dr
Hooksett, NH
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Columbia Univ Coll Of Physicians And Surgeons, New York Ny 10032
Graduation Year: 1994

Data Provided by:
Meredith J Selleck
(603) 622-6484
200 Technology Dr
Hooksett, NH
Specialty
Hematology / Oncology

Data Provided by:
Data Provided by:

Female Dangers

While breast cancer is the biggest and most publicized cancer threat American
women face, it is not the only female-specific cancer. Cervical, ovarian and uterine
malignancies affect thousands each year. Learn what to look out for so you don’t fall victim.

By Lisa James

May 2006

If someone says the words “female” and “cancer” to you, the first word that probably pops into your head is “breast.” After all, the numbers are hard to ignore: Almost 213,000 American women develop breast malignancies each year…and more than 40,000 die from them.

But a woman overlooks her reproductive tract at her peril; just ask actress Fran Drescher, who graced the cover of last year’s Annual ET Cancer Issue. In her book, Cancer Schmancer (Warner Books), Drescher explains how she saw nine doctors—count ’em, nine—before her uterine cancer was finally discovered and treated, leaving her unable to bear children. “Women need to understand gynecological cancers and the tests that can help detect them,” she writes. “We have to…become educated consumers, network among ourselves, and gain information and insight into getting diagnosed and getting treatment. Someone gimme a podium!”

Taking our lead from “The Nanny,” ET presents what you need to know about three cancers—cervical, ovarian and uterine—that should be on every woman’s radar. (Statistics given are 2006 estimates from the American Cancer Society [ACS].)

Uterine Cancer: A Hormonal Challenge

What it is: Most are endometrial cancers; they arise in the inner lining (endometrium) of the uterus, the part that grows and is shed over the course of a woman’s menstrual cycle. Tumors called sarcomas can develop in the muscle tissue, but account for only 2% to 4% of all uterine cancers.
Number of women affected: 41,200 cases of endometrial cancer (the most common reproductive-tract malignancy) and 7,350 deaths. It is one of the more treatable cancers though, with a five-year survival rate of 84%.

At greatest risk: Roughly 70% of all women affected are between the ages of 45 and 74. Endometrial cancer shares a lot of risk factors with ovarian cancer because excessive estrogen exposure promotes overgrowth of the uterine lining. Taking the drug tamoxifen for breast cancer also increases risk, as does having undergone pelvic radiation therapy. Genetic history is another factor, particularly in families affected by hereditary nonpolyposis colon cancer (HNPCC).

The symptoms: Abnormal bleeding, especially after menopause. Pain and weight loss can be signs of late-stage disease.

The tests: There are no standard screening tests for this kind of cancer. Abnormal bleeding may prompt your doctor to perform an endometrial biopsy, in which a thin needle is passed through the cervical opening to collect cells in the uterine lining.

Vital info: Try your best to drop those extra pounds. Obesity ups the risk of hormonally driven cancers because fat tissue can transform other hormones into estr...

Click here to read the rest of this article from Energy Times